Cytek Biosciences, Inc. (CTKB) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Cytek Biosciences, Inc. (CTKB) closed at USD 5.39 on 2026-10-14, a change of +28.5 % over the past year, with a market capitalization of USD 703.21M.

Cytek Biosciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Cytek Biosciences, Inc. key figures

Previous close

USD 5.39 (2026-10-14)

1-year change

+28.5 %

Market cap

USD 703.21M

Enterprise value

USD 467.67M

P/E ratio (trailing)

-8.59

P/E ratio (forward)

77.29

EPS (trailing)

-0.63

EPS (forward)

0.07

PEG ratio

n/a

Price to book

2.18

Revenue growth

5.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.00

Employees

682

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Cytek Biosciences, Inc. and compare it with other stocks.